# Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome

> **NCT00081458** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 84 (actual)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** Placebo
- **DRUG:** Teduglutide 0.05 mg/kg/d
- **DRUG:** Teduglutide 0.1 mg/kg/d

## Key facts

- **NCT ID:** NCT00081458
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05-25
- **Primary completion:** 2007-07-06
- **Final completion:** 2007-07-06
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2021-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00081458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00081458, "Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00081458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*